Search for: "Watson v. US"
Results 341 - 360
of 919
Sorted by Relevance
|
Sort by Date
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
6 Aug 2020, 6:57 pm
Prior to the landmark case of People v. [read post]
9 Nov 2010, 4:32 pm
It is interesting, however, that in 1975 the Faulks Committed recommended that there should be an action for a declaration that words used were defamatory within 5 years of death (paragraph 423(b)). [read post]
15 Nov 2015, 4:00 am
Charter values may not be used “to create ambiguity when none exists” and consequently has no role to play as an interpretive tool in this case. [read post]
21 Apr 2008, 11:52 am
U.S. 1st Circuit Court of Appeals, April 16, 2008 US v. [read post]
24 Apr 2017, 8:33 am
And with respect to the President, in particular, it is what undergirds the Supreme Court’s decision in Clinton v. [read post]
25 Aug 2014, 8:57 am
Some district courts have permitted originators to maintain declaratory actions against a generic manufacturer (see e.g. the Second Circuit in Cephalon v Watson (2009)). [read post]
16 Jul 2017, 4:22 pm
App'x 361, 364-65 (5th Cir. 2013) (per curiam); Watson v. [read post]
25 Jun 2013, 9:51 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
27 Jun 2011, 2:02 am
Relying on some “old” patent cases (including a House of Lords decision), the Court of Appeal in Blayney (trading as Aardvark Jewellery) v Clogau St David’s Gold Mines was willing to use a “notional royalty” as the measure of the damages. [read post]
2 Jan 2019, 12:34 pm
” Watson v. [read post]
15 Jun 2020, 12:00 am
See, e.g., Watson v. [read post]
15 Jun 2020, 3:00 pm
See, e.g., Watson v. [read post]
15 Oct 2011, 8:23 am
" Watson v. [read post]
4 Dec 2017, 3:27 pm
Sarvenaz just obtained a published writ of mandate (Rhue v. [read post]
21 Oct 2016, 12:56 pm
Watson, 273 F.3d 599, 602 (5th Cir. 2001) (describing probable cause as a `fair probability’ that a crime occurred, which is `more than a “bare suspicion” but less than a preponderance of the evidence’ (quoting U.S. v. [read post]
11 Jun 2007, 8:03 am
The ruling came in Watson v. [read post]
19 Apr 2011, 5:04 pm
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
23 Dec 2024, 11:18 am
“The State sought an order in the District Court allowing it to conduct a psychological evaluation of eight plaintiffs, including interviews focused on their ‘psychological and behavioral history, alcohol and drug use, school performance, and exposure to trauma. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
